مجهز به دستگاه های پیشرفته تشخیصی                                     پیشرو در ارائه خدمات آنلاین

Ackerman Atlas(chapter8)

portfolio image

Thyroid

  • برای بزرگنمایی عکسها کلیک را روی ان نگه دارید

  

 Figure 8.1 Immunoreactivity for calcitonin in thyroid C cells from a case of C-cell hyperplasia

 

Figure 8.2 Solid cell rest. The irregular branching shape of the nodule is characteristic

 

Figure 8.3 Black thyroid following minocycline therapy. (Courtesy of Dr. Maria Merino, Bethesda, Maryland.)

 

Figure 8.4 Thyroglossal duct cyst. The content of the cyst is gelatinous

 

 Figure 8.5 Distribution of heterotopic thyroid tissue. (From Lemmon WT, Paschal GW Jr. Lingual thyroid. Am J Surg. 1941;52:82-85.)

 

Figure 8.6 Branchial cleft cyst that has been partially opened to expose the inner surface, which is rendered irregular by the presence of innumer- able hyperplastic lymphoid follicles

 

 Figure 8.7 Granulomatous thyroiditis showing multiple granulomas centered in thyroid follicles

 

Figure 8.8 So-called palpation thyroiditis is a common incidental finding

 

 Figure 8.9 Cut surface of thyroid involved by Hashimoto thyroiditis. The appearance is reminiscent of a hyperplastic lymph node

 

Figure 8.10 Hashimoto thyroiditis showing lymphoid follicles with prominent germinal centers and oncocytic follicular epithelium

 

Figure 8.11 Dilated lymphatic vessels in Hashimoto thyroiditis result in characteristic "cracking spaces."

 

Figure 8.12 Hashimoto thyroiditis with extensive fibrosis, atrophy of follicular epithelium, and squamous metaplasia

 

Figure 8.13 A and B, Hashimoto thyroiditis with branchial cleftlike cysts. In the high-power microphotograph(B) one can appreciate the infiltration by the lymphocytes of the lining epithelium

 

 Figure 8.14 Riedel thyroiditis showing sclerosis, chronic inflammation,and parenchymal atrophy

 

 Figure 8.15 Inflammation of a vein in Riedel thyroiditis

 

Figure 8.16 Multifocal sclerosing thyroiditis, macroscopic appearance. Multiple fibrotic foci are scattered throughout the bisected thyroid lobe (arrows). (From Fellegara G, Rosai J. Gross appearance of multifocal fibrosing thyroiditis. Am J Surg Pathol. 2015;39(6):870.)

 

Figure 8.17 Multifocal sclerosing thyroiditis, microscopic appearance.Reactive atypia of follicular cells and "nodular fasciitis-like" stroma. The inset shows the irregular starlike fibrotic focus at low power

 

Figure 8.18 Dyshormonogenetic goiter. Gross appearance. Note the multinodular quality and the hemorrhagic changes in the larger nodules. (Courtesy of Dr. Michael Kashgarian, New Haven, Connecticut.)

 

Figure 8.19 Dyshormonogenetic goiter. Microscopic appearance. The follicles are hyperplastic and lined by follicular cells with marked nuclear pleomorphism

 

Figure 8.20 Outer aspect of diffuse thyroid hyperplasia in a patient with Graves disease. The gland is diffusely swollen and hyperemic

 

Figure 8.21 Out surface of thyroid gland with diffuse hyperplasia, showing a hyperemic "juicy" appearance.

 

Figure 8.22 Hyperplastic papillae protruding into dilated follicles in diffuse hyperplasia

 

 Figure 8.23 Lymphoid follicles with germinal centers and hyperplastic thyroid follicles in diffuse hyperplasia. Note the pale-staining quality of the colloid

 

Figure 8.24 Nodular hyperplasia of thyroid gland, with secondary cystic and hemorrhagic areas.

 

Figure 8.25 Low-power appearance of nodular hyperplasia. The hyperplastic nodules lack a capsule

 

 Figure 8.26 Nodular hyperplasia showing so-called Sanderson polster

 

Figure 8.27 Nodular hyperplasia with benign papillary formations protrud- ing toward the center of a cystically dilated follicle. Note the basal position of the nuclei

 

Figure 8.28 A and B, Gross appearance of two follicular adenomas. Both tumors show focal hemorrhagic areas

 

Figure 8.29 Intact fibrous capsule around a follicular adenoma

 

Figure 8.30 Microfollicular pattern of growth in a follicular adenoma

 

 Figure 8.31 Low-power (A) and high-power (B) views of follicular adenoma with bizarre nuclei. This feature is not a sign of malignancy and is analogous to that seen in many other endocrine tumors

 

Figure 8.32 Low-power view of hyalinizing trabecular adenoma

 

 Figure 8.33 Hyalinizing trabecular adenoma. A wide trabecula is seen in the center of the picture, with the tumor cells arranged perpendicular to the longest axis

 

Figure 8.34 Psammoma body formation in hyalinizing trabecular adenoma

 

Figure 8.35 Typical hyalinizing trabecular adenoma pattern (right), and a lesion with the features of a papillary carcinoma (left) are seen side by side, in a cervical lymph node metastasis. (From Rosai J, DeLellis RA, Carcangiu ML, Frabel WJ, Tallini G. Tumors of the Thyroid and Parathyroid Glands. AFIP Atlas of Tumor Pathology. Fourth series, Fascicle 21. Silver Spring, MD: American Registry of Pathology; 2014.)

 

 Figure 8.36 Gross appearance of a papillary carcinoma

 

  Figure 8.37 Gross appearance of a papillary carcinoma. The tumor shown exhibits a central area of fibrosis

 

Figure 8.38 Complex branching papillae in classic papillary carcinoma

 

 Figure 8.39 Nuclear features of papillary carcinoma: A, optically clear nuclei; B, nuclear pseudoinclusions

 

 Figure 8.40 Desmoplastic stromal reaction in papillary carcinoma

 

 Figure 8.41 Psammoma body formation in papillary carcinoma: A, within the stroma of the primary tumor; B, beneath the capsule of a cervical lymph node, without identifiable tumor cells

 

  Figure 8.42 Correlation of diagnostic categories (A) and molecular alterations (B) with the four basic morphologic features used to diagnose tumors of follicular cell derivation: papillary growth pattern, follicular growth pattern, presence of a tumor capsule (with or without invasion, of the capsule itself or of vessels), alterations of nuclear morphology of papillary carcinoma. PTC-Cl, classic papillary thyroid carcinoma; PTC-IFV, infiltrative follicular variant of papillary thyroid carcinoma (no tumor capsule); PTC-EFV, encapsulated follicular variant of papillary thyroid carcinoma (with or without invasion of capsule and vascular spaces); FA/FC, follicular adenoma/ follicular carcinoma. (From Tallini G, Tuttle RM, Ghossein RA. The history of the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2017;102;15-22.)

 

 Figure 8.43 Papillary thyroid carcinoma with RET/PTC rearrangement visualized using fluorescent probes that cover the RET locus at 10q11.2. Split fluorescent in situ hybridization signals indicating RET rearrangement are highlighted and magnified in the square insets

 

 Figure 8.44 Typical stellate appearance of papillary microcarcinoma

 

 Figure 8.45 On high power, the appearance of papillary microcarcinoma is no different from that of its larger counterpart

 

 Figure 8.46 The benign papillary formations of nodular hyperplasia point toward the center of the cystically dilated follicles

 

Figure 8.47 Benign papillary formations lined by columnar cells with basally located round normochromatic nuclei. The cytoplasm has a pale basophilic quality

 

 Figure 8.48 Follicular variant of papillary carcinoma. Note the clear overlapping nuclei

 

 Figure 8.49 Visual guide for scoring the nuclear features of papillary carcinoma using the three-point scoring scale. (From Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023-1029.)

 

Figure 8.50 Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). This tumor has follicular growth pattern, the nuclear alterations of papillary carcinoma, and is well circumscribed and without invasion (inset)

 

 Figure 8.51 Solid variant of papillary carcinoma. The nests are separated by fibrohyaline strands

 

Figure 8.52 So-called macrofollicular variant of papillary carcinoma. This lesion simulates nodular hyperplasia. The nuclear features that allow the diagnosis cannot be seen at this magnification

 

Figure 8.53 Diffuse sclerosing variant of papillary carcinoma. Note the diffuse pattern of growth, the heavy lymphocytic infiltrate, and the sclerosis

 

Figure 8.54 Prominent permeation of intrathyroid lymph vessels in diffuse sclerosing papillary carcinoma. Psammoma bodies are evident

 

Figure 8.55 Tall cell variant of papillary carcinoma. Note the abundant granular acidophilic cytoplasm with oncocyte-like features

 

Figure 8.56 Columnar cell variant of papillary carcinoma. The papillae are lined by a pseudostratified layer of spindle tumor cells

 

Figure 8.57 A and B, Cribriform-morular variant of papillary carcinoma. The cribriform quality of the tumor is particularly well appreciated in B

 

 Figure 8.58 Hobnail variant of papillary carcinoma. Atypical nuclei with "hobnail" surface bulges, micropapillae, and discohesive cells (Courtesy of Drs. Asioli and Lloyd)

 

 Figure 8.59 Papillary thyroid carcinoma metastatic to cervical lymph node. The tumor has undergone cystic change, simulating on low power the appearance of a branchial cleft cyst; small papillary formations are present

 

Figure 8.60 Capsular (A) and vascular (B) invasion in minimally invasive follicular carcinoma

 

 Figure 8.61 A and B, Reactive vascular proliferation in the capsule of a follicular neoplasm. On high power (B) the lesion has a papillary configuration

 

 Figure 8.62 Ultrastructural appearance of Hürthle cell (oncocytic) tumor of thyroid gland. A, The cytoplasm is packed with mitochondria. Secretory product is located toward the lumen, which is filled with colloid. B, Variably sized mitochondria with prominent cristae. (A, x3840; B, x11,230.)

 

Figure 8.63 Gross appearance of Hürthle cell (oncocytic) carcinoma. The cut surface shows a tan color and a necrotic hemorrhagic center

 

 Figure 8.64 Hürthle cell (oncocytic) adenoma showing follicular pattern of growth and intact thin capsule

 

Figure 8.65 Hürthle cell (oncocytic) carcinoma. A, The tumor has a predominantly solid pattern of growth. B, Extensive vascular invasion

 

 Figure 8.66 Hürthle cell (oncocytic) neoplasm with a papillary pattern of growth. The nuclear features of the papillary family of neoplasms are absent, and therefore this tumor should not be classified as a papillary carcinoma

 

Figure 8.67 Follicular neoplasm with cytoplasmic clear change. The clearing has a finely granular quality

 

Figure 8.68 Hürthle cell neoplasm with focal cytoplasmic clear change

 

 Figure 8.69 Hürthle cell neoplasm showing oncocytic features in the basal half of the tumor cells and clearing of the apical half 

 

Figure 8.70 So-called signet ring adenoma, resulting from intracytoplasmic accumulation of thyroglobulin

 

 Figure 8.71 A and B, Mucoepidermoid carcinoma of thyroid. (Courtesy of Dr. K. Franssila, Helsinki.)

 

 Figure 8.72 Sclerosing mucoepidermoid carcinoma with eosinophilia occurring in a thyroid gland affected by Hashimoto thyroiditis. The neoplasm, which almost entirely replaces a lobe, has a well-circumscribed quality. (Courtesy of Dr. Josie Zaroway, Edmonton, Canada.)

 

Figure 8.73 Sclerosing mucoepidermoid carcinoma with eosinophilia. A, The pattern of growth is solid and squamoid and is associated with a massive eosinophilic infiltration. B, The formation of tissue spaces results in a pseudovascular appearance

 

Figure 8.74 Diagnostic criteria for poorly differentiated thyroid carcinoma. HPF: high power field; random mitotic counts in areas with solid/trabecular/ insular (STI) growth pattern (From Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31(8):1256-1264.)

 

Figure 8.75 Low-power view of poorly differentiated thyroid carcinoma, showing a well-developed insular pattern

 

 Figure 8.76 On high power, the cells of insular carcinoma show round, medium-sized nuclei with a smooth contour and hyperchromasia

 

 Figure 8.77 Poorly differentiated (insular) carcinoma. The peritheliomatous pattern of growth results from necrosis associated with preservation of the tumor cells that are closer to nutrient vessels

 

 Figure 8.78 Poorly differentiated carcinoma showing trabecular pattern of growth rather than insular formations

 

 Figure 8.79 Poorly differentiated carcinoma of thyroid of insular type showing immunoreactivity for thyroglobulin

 

 Figure 8.80 Undifferentiated carcinoma of the thyroid entirely replacing the gland and extending into the surrounding skeletal muscle

 

 Figure 8.81 Undifferentiated carcinoma of the spindle cell type

 

 Figure 8.82 Undifferentiated carcinoma of giant cell type

 

 Figure 8.83 A and B, Combined poorly differentiated and undifferentiated thyroid carcinoma. Immunoreactivity for thyroglobulin is restricted to the poorly differentiated areas (B)

 

 Figure 8.84 Undifferentiated thyroid carcinoma showing residual papillary carcinoma

 

 Figure 8.85 Gross appearance of medullary carcinoma. Note its unencapsulated quality, solid appearance, and yellowish tan color

 

 Figure 8.86 Medullary carcinoma. Low-power microscopic view showing solid pattern of growth and deposition of amyloid

 

 Figure 8.87 Medullary carcinoma with pseudopapillary pattern of growth resulting from lack of cohesiveness of tumor cells

 

 Figure 8.88 Medullary carcinoma of oncocytic type. The appearance closely simulates that of Hürthle cell carcinoma. Clues to the diagnosis are represented by the amphophilic (rather than eosinophilic) staining quality of the cytoplasm and the prominent fibrous septation. This tumor was strongly immunoreactive for calcitonin

 

 Figure 8.89 Cytologic appearance of medullary carcinoma. The nuclei have clumped chromatin. An amorphous material compatible with amyloid is present

 

Figure 8.90 Medullary carcinoma showing immunocytochemical positivity for calcitonin (A), chromogranin (B), and CEA (C)

 

 Figure 8.91 Ultrastructural appearance of medullary carcinoma. Portions of two tumor cells show multiple dense secretory granules in the cytoplasm. Each granule is surrounded by a single membrane, and the dense central portion is separated from it by a clear zone. Inset shows both oriented and randomly placed amyloid filaments and may be contrasted with larger banded collagen fibers. (Courtesy of Dr. J.S. Meyer, St Louis.)

 

 Figure 8.92 Thyroid paraganglioma showing well-formed Zellballen

 

 Figure 8.93 S-100 protein-positive sustentacular cells at the periphery of the "Zellballen" in paraganglioma of thyroid

 

Figure 8.94 A and B, So-called sequestered (parasitic) thyroid nodule occurring in association with a gland involved by Hashimoto thyroiditis. The combination of oxyphilic change and germinal center formation in the sequestered nodule results in an appearance that can be confused with thyroid carcinoma metastatic to a lymph node

 

 Figure 8.95 Ectopic thyroid follicles in lymph node. The follicles are scanty, centered in the lymph node capsule, and devoid of structural and cytologic abnormalities

 

 Figure 8.96 Malignant lymphoma of thyroid. A, Low-power view showing a diffuse pattern of growth. B, Medium-power view showing tumor cells surrounding lymphoid follicles. One of the follicles shows "packing' of the lumen by lymphoid cells, a feature of diagnostic significance

 

Figure 8.97 Hodgkin lymphoma involving the thyroid gland. A, Low-power view showing a nodular pattern of growth. B, High-power view showing a polymorphic infiltrate containing Reed-Sternberg cells. (Courtesy of Dr. Juan José Segura, San José, Costa Rica.) 

 

Figure 8.98 Langerhans cell histiocytosis involving the thyroid gland. A, Infiltrate composed of Langerhans cells and eosinophils. B, S-100 protein immunoreactivity of Langerhans cells

 

 Figure 8.99 Angiosarcoma of thyroid. The tumor is well differentiated and composed of anastomosing vascular channels lined by somewhat epithelioid endothelial cells

 

Figure 8.100 Epithelioid angiosarcoma of thyroid. Note the prominent nucleoli

 

Figure 8.101 Keratin immunoreactivity in thyroid angiosarcoma. There was also positivity for endothelial markers 

 

Figure 8.102 Lobular carcinoma of the breast with signet ring features metastatic to thyroid

 

Figure 8.103 Renal cell carcinoma of clear cell type metastatic to thyroid. Note the blood-filled glands